What Makes Glutathione Effective for Skin
Lilly is building a multi-engine growth machine: Alzheimer's Treatment Kisunla (Donanemab) - FDA-approved for early Alzheimer's, first proven to slow cognitive decline Represents a breakthrough in neurodegenerative disease treatment Oncology & Immunology Verzenio (breast cancer): $1.47B in Q3 2025 (+7% YoY) Jaypirca and Omvoh expanding in oncology and autoimmune markets Radiopharmaceutical investments through Point Biopharma ($1.4B acquisition) and Aktis Oncology partnership Pipeline Depth 40+ programs in Phase 2/3 across neuroscience, immunology, and cardiology Recent acquisitions: Scorpion Therapeutics, SiteOne Therapeutics, Adverum Biotechnologies Lilly isn't a one-trick pony
Whilst GLP-1 receptor agonists have brought attention to this phenomenon, numerous evidence-based strategies can help reduce food noise without medication
More Melanotan 1 Peptide: Stunning Tanning & Effortless Melanin Boost Curious about the science behind that flawless golden glow
In their marketing, telehealth companies claim that compounded GLP-1s in small doses starting lower than FDA-approved doses from Novo Nordisk and Eli Lilly can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline
CJC-1295 stimulates pituitary GH release via the GHRH receptor while ipamorelin stimulates the same cells via the GHS-R1a (ghrelin) receptor